Acute bronchiolitis is a disease affecting infants and occurring by epidemi
cs, due to its highly contagious nature. The increased number of visits and
hospital admissions caused by bronchiolitis make it a real public health p
roblem. Its management is a subject of passionate debate by various paediat
ric teams. The treatment of acute bronchiolitis is essentially symptomatic
and is based on hydration, oxygen therapy (when necessary) and respiratory
physiotherapy. No drug class, particularly bronchodilators or corticosteroi
ds, has yet been shown to be effective. However, in children with a persona
l and/or family history of atopy, or in children presenting with severe res
piratory distress, the prescription of a beta 2-mimetic nebulizer can be pr
oposed, but it does not appear logical to continue such treatment when it i
s ineffective.